AgeneBio's Seed VC - II Round

AgeneBio raised a round of funding on November 18, 2013. Investors include New Enterprise Associates.

AgeneBio is developing therapies for people who have Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer's disease (AD). The company has a new clinical strategy to help address the therapeutic nee…

Articles about AgeneBio's Seed VC - II Round: